期刊
DRUG DISCOVERY TODAY
卷 25, 期 4, 页码 739-747出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.drudis.2020.01.019
关键词
-
资金
- FCT/MCTES [UID/QUI/50006/2019, UIDB 50006/2020]
- Ministerio de Ciencia Innovacion y Universidades, Spain [RTI2018-097504-B-I00]
Cardiovascular diseases (CVDs) are the most common cause of death from noncommunicable diseases worldwide. In addition to the classical CVD risk factors related to lifestyle and/or genetic background, exposure to an adverse intrauterine environment compromises fetal development leading to low birth weight and increasing offspring susceptibility to develop CVDs later in life, particularly hypertension - a process known as fetal programming of hypertension (FPH). In FPH animal models, permanent alterations have been detected in gene expression, in the structure and function of heart and blood vessels, compromising cardiovascular physiology and favoring hypertension development. This review focuses on the role of the sympathetic nervous system and its interplay with G-protein-coupled receptors, emphasizing strategies that envisage the prevention and/or treatment of FPH through interventions in early life.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据